TransMedics Group Inc. [NASDAQ:TMDX] prices stumbled -5.02% on Tuesday.
With a current price of $13.80, TMDX is active in the Medical Devices industry and it looks to be on-track for a five-day slide of -3.56%.
In addition, TMDX’s high over the last year is $24.18 and the low is $10.10. Over the last two 52 weeks, the company is trading -41.89%, while the S&P 500 is trading -0.18%.
The Bears are coming
Holding a Market Cap of $371.63 million, TransMedics Group Inc. has seen a trading range over the last year of $10.10-$24.18.
For the last five days, TMDX is down from its last closing price. The average shares trading hands each day is 166.51K.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for TMDX. When we apply the Elder Force Index to TransMedics Group Inc., we are seeing an Elder Force Indicator number of -1282285.88.
In the last quarter, TMDX made a profit of 1.91 million. TransMedics Group Inc. also saw quarter revenue growth year over year of 81.33%.
Looking at popular technical indicators, the company’s 5-day moving average is 14.24 compared to the 50-day moving average of 5.11%. So, we are clearly seeing an upward trajectory here.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. TMDX currently holds a 9-day RSI of 22.67%, while 100-day RSI stands at 46.40%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. TMDX’s 9-day MACD is -0.42 and the company’s 100-day MACD stands at -2.39.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 23.26% by insiders and 76.49% by institutions. Regarding institutional holdings, FMR, LLC owns 14.55%, while the second top holder, Abrams Capital Management, L.P., currently owns 12.89%.
Over the last six months, insiders have sold 2,000 with the most recent transaction from Carey John F, VP of Operations, with a sell at price 17.59 per share.
Overall, the recommended rating for TMDX is Strong Buy. Currently, the company has 5 analysts watching the stock, and the average quarterly earnings estimate is -0.32. Quarterly revenue estimates are averaging 5.55M with the high estimate reaching 6.2M and the low at 4.9M.
To review, the current 1-year target estimate is sitting at 21.00, while the current price 13.80. Based on this, we expect the stock to rise considering the aforementioned fundamentals.